These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 30826404)
1. Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease. Gupta J; Fatima MT; Islam Z; Khan RH; Uversky VN; Salahuddin P Int J Biol Macromol; 2019 Jun; 130():515-526. PubMed ID: 30826404 [TBL] [Abstract][Full Text] [Related]
2. Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients. Bhattacharya S Curr Pharm Biotechnol; 2023; 24(9):1108-1121. PubMed ID: 36305141 [TBL] [Abstract][Full Text] [Related]
3. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease. Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease. Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575 [TBL] [Abstract][Full Text] [Related]
5. Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease? Dabur M; Loureiro JA; Pereira MC Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340267 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders. Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530 [TBL] [Abstract][Full Text] [Related]
7. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446 [TBL] [Abstract][Full Text] [Related]
8. Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease. Jain U; Johari S; Srivastava P Mol Neurobiol; 2024 Apr; 61(4):1969-1989. PubMed ID: 37831361 [TBL] [Abstract][Full Text] [Related]
9. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease. Gao N; Sun H; Dong K; Ren J; Qu X Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633 [TBL] [Abstract][Full Text] [Related]
10. Neurotherapeutic applications of nanoparticles in Alzheimer's disease. Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407 [TBL] [Abstract][Full Text] [Related]
11. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization. Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747 [TBL] [Abstract][Full Text] [Related]
12. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier. Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419 [TBL] [Abstract][Full Text] [Related]
13. Theranostic Nanoparticles for RNA-Based Cancer Treatment. Revia RA; Stephen ZR; Zhang M Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134 [TBL] [Abstract][Full Text] [Related]
14. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease. Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248 [TBL] [Abstract][Full Text] [Related]
15. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease. Huo X; Zhang Y; Jin X; Li Y; Zhang L J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054 [TBL] [Abstract][Full Text] [Related]